AMST Amesite Inc. Insider Trading

CEO Sastry bought 174.2K shares of AMST at $1.44; position now 1.05M shares. Stock currently $0.79, down 83.5% from 52-week high.

Sastry Ann Marie, CEO of Amesite Inc., purchased 174,216 shares at $1.44 on 2026-04-28 in a private placement transaction (not a discretionary open-market purchase), increasing her holdings by 19.9% to 1.05M shares. The stock has since declined sharply to $0.79, representing an 83.5% drop from its 52-week high of $4.78 and a 55.1% loss in just 30 days. Amesite's fundamentals are severely stressed: the company reported $-732.5K net income in the latest quarter, annual revenue contracted 33.8% year-over-year, and the market cap stands at only $3.6M. The CEO's prior buy history at this ticker shows mixed results (prior buy on 2025-01-07 posted a 30-day gain of 8.3% but a 90-day loss of 27.0%), and none of her prior buys across all tickers have realized positive 90-day returns. This filing should be understood in the context of the private-placement structure rather than as a discretionary conviction signal.

Director Parmer George bought 243,902 AMST shares at $1.44 (now $0.79, -83.5% from 52-week high) via private placement, raising stake 75.5% despite negative fundamentals.

Director Parmer George's $350.0K purchase of 243,902 shares represents a significant 75.5% increase in his stake, but the transaction is a private placement — not a discretionary open-market purchase — and should not be interpreted as a buying signal driven by insider conviction. The timing is notable: the stock trades at $0.79, down 83.5% from its 52-week high of $4.78 and down 55.1% over the past 30 days, while the company faces deteriorating fundamentals including a -33.8% annual revenue decline, a latest-quarter net loss of $-732,548.00, and unprofitability on a full-year basis with a $3.6M market cap. His prior buy at AMST on 2025-01-07 resulted in a 90-day loss of -27.0%, and across his broader 16 prior open-market buys, the 90-day win rate stands at only 56.25%, suggesting limited predictive value in his historical entry points. The structure of this transaction as a private placement limits its signal value for retail investors assessing insider confidence in the company's recovery prospects.